These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 8646551)

  • 1. LacZ gene transfer into tumor cells abrogates tumorigenicity and protects mice against the development of further tumors.
    Abina MA; Lee MG; Descamps V; Cordier L; Lopez M; Perricaudet M; Haddada H
    Gene Ther; 1996 Mar; 3(3):212-6. PubMed ID: 8646551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor cell surface expression of granulocyte-macrophage colony-stimulating factor elicits antitumor immunity and protects from tumor challenge in the P815 mouse mastocytoma tumor model.
    Soo Hoo W; Lundeen KA; Kohrumel JR; Pham NL; Brostoff SW; Bartholomew RM; Carlo DJ
    J Immunol; 1999 Jun; 162(12):7343-9. PubMed ID: 10358185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Importance of B7-1-expressing host antigen-presenting cells for the eradication of B7-2 transfected P815 tumor cells.
    La Motte RN; Sharpe AH; Bluestone JA; Mokyr MB
    J Immunol; 1998 Dec; 161(12):6552-8. PubMed ID: 9862681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced tumorigenicity and augmented leukocyte infiltration after monocyte chemotactic protein-3 (MCP-3) gene transfer: perivascular accumulation of dendritic cells in peritumoral tissue and neutrophil recruitment within the tumor.
    Fioretti F; Fradelizi D; Stoppacciaro A; Ramponi S; Ruco L; Minty A; Sozzani S; Garlanda C; Vecchi A; Mantovani A
    J Immunol; 1998 Jul; 161(1):342-6. PubMed ID: 9647242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complete recovery of mice from a pre-established tumor by direct intratumoral delivery of an adenovirus vector harboring the murine IL-2 gene.
    Cordier L; Duffour MT; Sabourin JC; Lee MG; Cabannes J; Ragot T; Perricaudet M; Haddada H
    Gene Ther; 1995 Jan; 2(1):16-21. PubMed ID: 7712329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating levels of IL-10 are critically related to growth and rejection patterns of murine mastocytoma cells.
    Grohmann U; Silla S; Belladonna ML; Bianchi R; Orabona C; Puccetti P; Fioretti MC
    Cell Immunol; 1997 Nov; 181(2):109-19. PubMed ID: 9398398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of P815 tumor immunity by recombinant Semliki Forest virus expressing the P1A gene.
    Colmenero P; Liljeström P; Jondal M
    Gene Ther; 1999 Oct; 6(10):1728-33. PubMed ID: 10516722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intra-pinna anti-tumor vaccination with self-replicating infectious RNA or with DNA encoding a model tumor antigen and a cytokine.
    Schirmacher V; Förg P; Dalemans W; Chlichlia K; Zeng Y; Fournier P; von Hoegen P
    Gene Ther; 2000 Jul; 7(13):1137-47. PubMed ID: 10918481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progressive growth of immunogenic tumors: relationship between susceptibility of ascites P815 tumor cells to T-cell-mediated lysis and immune destruction in vivo.
    Fahey JR; Hines DL
    Cancer Res; 1987 Sep; 47(18):4759-65. PubMed ID: 3113723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential requirement for CD4 help in the development of an antigen-specific CD8+ T cell response depending on the route of immunization.
    Bour H; Horvath C; Lurquin C; Cerottini JC; MacDonald HR
    J Immunol; 1998 Jun; 160(11):5522-9. PubMed ID: 9605156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intracamerally induced concomitant immunity: mice harboring progressively growing intraocular tumors are immune to spontaneous metastases and secondary tumor challenge.
    Niederkorn JY; Streilein JW
    J Immunol; 1983 Nov; 131(5):2587-94. PubMed ID: 6415174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Host B7-1 and B7-2 costimulatory molecules contribute to the eradication of B7-1-transfected P815 tumor cells via a CD8+ T cell-dependent mechanism.
    La Motte RN; Sharpe AH; Bluestone JA; Mokyr MB
    J Immunol; 1999 Apr; 162(8):4817-23. PubMed ID: 10202025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenoviral interleukin-2 gene transfer into P815 tumor cells abrogates tumorigenicity and induces antitumoral immunity in mice.
    Haddada H; Ragot T; Cordier L; Duffour MT; Perricaudet M
    Hum Gene Ther; 1993 Dec; 4(6):703-11. PubMed ID: 8186285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune privilege is extended, then withdrawn, from allogeneic tumor cell grafts placed in the subretinal space.
    Wenkel H; Chen PW; Ksander BR; Streilein JW
    Invest Ophthalmol Vis Sci; 1999 Dec; 40(13):3202-8. PubMed ID: 10586943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Humoral mechanisms of the membrano-toxic effects of mastocytoma P815 and leukemia EL4 cells].
    Medvedev AE; Fuks BB
    Biull Eksp Biol Med; 1989 Aug; 108(8):194-6. PubMed ID: 2508789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo and in vitro antitumor activity expressed by cells of concomitantly immune mice.
    Tuttle RL; Knick VC; Stopford CR; Wolberg G
    Cancer Res; 1983 Jun; 43(6):2600-5. PubMed ID: 6133611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenoviral transfer of xenogeneic MHC class I gene results in loss of tumorigenicity and inhibition of tumor growth.
    Campbell I; Moyana T; Carlsen S; Zheng C; Xiang J
    Cancer Gene Ther; 2000 Jan; 7(1):37-44. PubMed ID: 10678354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-2 gene delivery within an established murine tumor causes its regression without proliferation of preexisting antitumor-specific CTL.
    Levraud JP; Duffour MT; Cordier L; Perricaudet M; Haddada H; Kourilsky P
    J Immunol; 1997 Apr; 158(7):3335-43. PubMed ID: 9120291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antitumor effect of CD40 ligand: elicitation of local and systemic antitumor responses by IL-12 and B7.
    Nakajima A; Kodama T; Morimoto S; Azuma M; Takeda K; Oshima H; Yoshino S; Yagita H; Okumura K
    J Immunol; 1998 Aug; 161(4):1901-7. PubMed ID: 9712059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Helper cells active in the generation of cytotoxicity to a syngeneic tumor.
    Hancock EJ; Kilburn DG; Levy JG
    J Immunol; 1981 Oct; 127(4):1394-7. PubMed ID: 6168688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.